Thus, if PD-1 blockade in solid tumors reverses a obesity-related impairment of cytotoxic CD8 + T cells functioning, this mechanism could not apply to cHL [23, 24]. The gene discussed is CD8A; the disease is obesity due to melanocortin 4 receptor deficiency.